[HTML][HTML] Cytokine registry in stroke patients (CRISP): Protocol of a prospective observational study

M Farooqui, A Ikram, S Suriya, S Saleem, SA Quadri… - Medicine, 2020 - journals.lww.com
Inflammation is an important pathophysiological process after an acute stroke (AS). Pro-and
anti-inflammatory molecules (cytokines and interleukins) are the key players during this …

[HTML][HTML] The prognostic value of serum cytokines in patients with acute ischemic stroke

X Li, S Lin, X Chen, W Huang, Q Li, H Zhang… - Aging and …, 2019 - ncbi.nlm.nih.gov
The inflammatory response is an unavoidable process and contributes to the destruction of
cerebral tissue during the acute ischemic stroke (AIS) phase and has not been addressed …

Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management

L Ramiro, A Simats… - Therapeutic …, 2018 - journals.sagepub.com
Stroke is the fifth leading cause of death and the most frequent cause of disability worldwide.
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …

[HTML][HTML] Blood/brain biomarkers of inflammation after stroke and their association with outcome: from C-reactive protein to damage-associated molecular patterns

A Bustamante, A Simats, A Vilar-Bergua… - …, 2016 - Elsevier
Stroke represents one of the most important causes of disability and death in developed
countries. However, there is a lack of prognostic tools in clinical practice to monitor the …

Update on inflammatory biomarkers and treatments in ischemic stroke

A Bonaventura, L Liberale, A Vecchié… - International journal of …, 2016 - mdpi.com
After an acute ischemic stroke (AIS), inflammatory processes are able to concomitantly
induce both beneficial and detrimental effects. In this narrative review, we updated evidence …

Inflammation biomarkers in acute ischemic stroke according to different etiologies

C Meisinger, D Freuer, T Schmitz, M Ertl… - European Journal of …, 2024 - Wiley Online Library
Background High throughput technologies provide new opportunities to further investigate
the pathophysiology of ischemic strokes. The present cross‐sectional study aimed to …

Inflammatory biomarkers of ischemic stroke

A Tirandi, C Sgura, F Carbone, F Montecucco… - Internal and emergency …, 2023 - Springer
Ischemic stroke remains the second leading cause of death and among the major causes of
morbidity worldwide. Therapeutic options are currently limited to early reperfusion strategies …

[HTML][HTML] Neuroinflammatory biomarkers: from stroke diagnosis and prognosis to therapy

A Simats, T García-Berrocoso, J Montaner - Biochimica et Biophysica Acta …, 2016 - Elsevier
Stroke is the third leading cause of death in industrialized countries and one of the largest
causes of permanent disability worldwide. Therapeutic options to fight stroke are still limited …

The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome

H Worthmann, AB Tryc, A Goldbecker, YT Ma… - Cerebrovascular …, 2010 - karger.com
Background: Early inflammation has been suggested as an important factor contributing to
unfavorable prognosis after acute ischemic stroke. The present study aimed to clarify the …

[HTML][HTML] Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets

DN Doll, TL Barr, JW Simpkins - Aging and disease, 2014 - ncbi.nlm.nih.gov
Inflammatory mechanisms both in the periphery and in the CNS are important in the
pathophysiologic processes occurring after the onset of ischemic stroke (IS). Cytokines are …